Bayesian Capital Management’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,600
Closed -$380K 568
2025
Q3
$380K Buy
+2,600
New +$393K 0.08% 336
2025
Q2
Sell
-1,412
Closed -$232K 920
2025
Q1
$232K Buy
+1,412
New +$235K 0.04% 452
2024
Q4
Sell
-5,400
Closed -$1.06M 1050
2024
Q3
$1.06M Sell
5,400
-8,000
-60% -$1.47M 0.12% 236
2024
Q2
$2.32M Buy
13,400
+3,600
+37% +$599K 0.27% 95
2024
Q1
$1.66M Buy
+9,800
New +$1.84M 0.16% 185
2022
Q4
Sell
-1,379
Closed -$204K 1067
2022
Q3
$204K Sell
1,379
-21,821
-94% -$3.65M 0.04% 519
2022
Q2
$3.99M Buy
+23,200
New +$4.01M 0.74% 10
2020
Q2
Sell
-2,644
Closed -$311K 836
2020
Q1
$311K Buy
2,644
+671
+34% +$88.3K 0.07% 442
2019
Q4
$261K Sell
1,973
-5,527
-74% -$687K 0.04% 467
2019
Q3
$934K Buy
+7,500
New +$905K 0.18% 160
2019
Q2
Sell
-14,463
Closed -$1.46M 699
2019
Q1
$1.46M Buy
14,463
+4,802
+50% +$436K 0.28% 107
2018
Q4
$826K Buy
+9,661
New +$870K 0.17% 193
2018
Q2
Sell
-8,900
Closed -$743K 758
2018
Q1
$743K Sell
8,900
-7,800
-47% -$614K 0.19% 172
2017
Q4
$1.2M Buy
+16,700
New +$1.15M 0.25% 138
2017
Q3
Sell
-23,400
Closed -$1.46M 676
2017
Q2
$1.46M Buy
+23,400
New +$1.38M 0.54% 37
2017
Q1
Sell
-34,800
Closed -$1.86M 722
2016
Q4
$1.86M Buy
34,800
+11,600
+50% +$590K 0.46% 26
2016
Q3
$1.21M Buy
+23,200
New +$1.17M 0.79% 14
2016
Q1
Sell
-6,900
Closed -$331K 454
2015
Q4
$331K Buy
+6,900
New +$312K 0.47% 76

Other funds holding ZTS

Bayesian Capital Management's ZTS Position: Q4 2025 in Review

Bayesian Capital Management sold out of Zoetis (ZTS) in Q4 2025, closing a stake of 2,600 shares — an estimated $380K sold.

Bayesian Capital Management first reported a position in ZTS in Q4 2015 and held it in 18 quarters. The position peaked at $3.99M in Q2 2022. 1,682 funds tracked by Wall St. Rank hold ZTS as of Q4 2025.

  • Bayesian Capital Management reported no remaining Zoetis position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 2,600 Zoetis shares in Q4 2025, an estimated $380K.
  • Bayesian Capital Management first reported a position in Zoetis in Q4 2015 and held it in 18 quarters.
  • Bayesian Capital Management's Zoetis position peaked at $3.99M in Q2 2022.
  • 1,682 funds tracked by Wall St. Rank held Zoetis as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.